{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "02/17/2021",
      "package_ndc": "67457-445-60",
      "generic_name": "Rifampin Injection",
      "contact_info": "800-796-9526",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: Q4 2026",
      "openfda": {
        "application_number": [
          "ANDA065421"
        ],
        "brand_name": [
          "RIFAMPIN"
        ],
        "generic_name": [
          "RIFAMPIN"
        ],
        "manufacturer_name": [
          "Mylan Institutional LLC"
        ],
        "product_ndc": [
          "67457-445"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "RIFAMPIN"
        ],
        "rxcui": [
          "312821"
        ],
        "spl_id": [
          "2e65f8eb-0189-46db-9458-98ef7f67a156"
        ],
        "spl_set_id": [
          "8be91604-d7cd-4f2b-997d-e3364e4092e5"
        ],
        "package_ndc": [
          "67457-445-60"
        ],
        "nui": [
          "N0000175500",
          "M0019113"
        ],
        "pharm_class_epc": [
          "Rifamycin Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Rifamycins [CS]"
        ],
        "unii": [
          "VJT6J7R4TR"
        ]
      },
      "update_date": "10/19/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)",
      "company_name": "Mylan Institutional, a Viatris Company",
      "shortage_reason": "Demand increase for the drug",
      "status": "Current"
    }
  ]
}